Elbit Imaging: Is Series XI Really Unlocking Afula and Herzog 3?

What This Follow-Up Is Testing

The main article already established that Elbit Imaging has built a real residential-development platform, but one critical question was still open: is the new public-debt layer genuinely moving projects forward, or is it mainly transferring old pressure points into a cleaner liability structure. This follow-up isolates the first real test of Series XI through two very specific assets: Phase A of Park Tzameret in Afula and Herzog 3 in Bat Yam.

The short answer is partial. Series XI is indeed meant to fund the equity component the company needs in order to move projects forward, and it is built directly around the surplus rights of Afula and Herzog 3. But the money does not land as free corporate liquidity. It sits in a trust account, is released in stages, is tied to documentation, liens, and an LTV test, and in the event of a prolonged delay can even be pushed into early redemption. This is not an automatic project opening. It is public bridge capital with a timer attached.

That means the test of the bond is not the next income statement. It is much simpler and much harsher: does Afula reach first drawdown and actual construction start, and does Herzog 3 move from a building permit to real movement in issuance proceeds and execution. If yes, it will be fair to say that Series XI truly opened a door. If not, what the market got was mainly an old financing strain repackaged into a more orderly wrapper.

What Series XI Actually Does

On February 12, 2026, the company completed a Series XI bond issue of NIS 67.5 million par value. In the shelf offering report, the company estimated net proceeds of about NIS 66.4 million, and the annual report makes clear that the intended use is to fund real-estate activity, with an emphasis on the equity component required in order to advance projects. That is the key framing point: the series was not designed to replace the project lender or to fund construction on its own. It is meant to fill the equity hole that the developer has to bring before the bank really moves.

That also explains the collateral structure. The series is secured, among other things, by 100% of the surplus rights from Afula Phase A and from the Bat Yam project, Herzog 3. In Afula the point is even sharper: through Elbit Megoorim, the company holds only 67% of the project company, but it obtained partner consent so that 100% of the Phase A surplus rights would be pledged to the trustee. That strengthens the bondholders' collateral, but it weakens the company's freedom over the first future surplus.

What matters even more is the order of priority. The offering report states explicitly that Series XI bondholders' rights in those surpluses are subordinate to the project lender's rights, and that until the lender has actually released money into the pledged account there are, in practice, no surpluses securing the bonds. In plain English, the collateral looks strong on paper, but it only starts to work after the bank has been paid and after real surplus has been created. Series XI is not a bank-circumventing key. It sits behind the bank and waits for the project to mature.

The proceeds-release mechanism says the same thing. The full issuance proceeds are deposited into a trust account and released to the company in stages. If the lien perfection and documentation are completed first in Afula, the company receives only the Afula-related portion first. The rest stays locked until the Bat Yam conditions are also completed. And if the Afula or Bat Yam conditions are not met within 120 days from the date the full proceeds were received by the lead manager, the company is supposed to carry out a forced early redemption, partial or full, with a possible 30-day extension by the trustee. This is the detail that is easiest to miss. Series XI is not just more or less expensive capital. It is capital with a clock on it.

Against that, the covenant backdrop is relatively calm. In the annual report's covenant table, the company shows, as of December 31, 2025, equity of NIS 87 million including minority interests, against a minimum requirement of NIS 42.5 million, and an equity-to-balance-sheet ratio of 26% against a 13% minimum for Series XI. So the right place to start is here: this does not look like a raise that was forced by an immediate covenant wall. It looks much more like an attempt to build an execution-accelerating equity layer. That is exactly why the question of whether it really unlocks the projects becomes sharper, not softer.

Afula: The Headline Is NIS 297 Million, but the Real Test Is Smaller and Harder

Afula is the right place to start because this is where the gap between headline and reality is clearest. On one side, the financing agreement for Phase A of Park Tzameret speaks about a maximum framework of NIS 297 million, including cash credit and Sale Law guarantees. That sounds like a project that is already open. On the other side, the financial credit itself is capped at NIS 90 million, and a meaningful part of that relates to land financing that already existed. So the big headline does not tell you how much money can really start moving into construction, and certainly not how much of it is free.

The important document is not the size of the framework but the conditions for the first draw. Before the company can draw money from the project account, it must, among other things, repay a NIS 6 million loan to Elbit Megoorim by April 20, 2026, begin construction by May 30, 2026, deliver an updated zero report or first monitoring report, obtain all permits and approvals, presell at least 40 housing units for aggregate consideration of at least NIS 71.4 million, and contribute NIS 35.8 million of equity. Only after at least 91 units are sold for at least NIS 163 million, and subject to at least 25% project completion, does the required equity fall to NIS 25.6 million.

This chart sharpens what the NIS 297 million headline blurs: what opens Afula is not the existence of a framework, but compliance with a very strict chain of sales, equity, approvals, and timing conditions.

There is also one detail that adds useful color. The Series XI trust deed says that at the signing date there were already binding sales contracts for 16 housing units in Phase A, and that on December 7, 2025 a building permit for Phase A had already been received. That means part of the work had already been done before the issuance was completed. The conclusion is important: Series XI did not create Afula from scratch. It entered a project that already had a permit, financing, and early sales, and was meant to help it cross the developer-equity bottleneck and move from paperwork into drawdown and execution.

At the same time, the project-specific collateral disclosure adds another layer of caution. It shows expected withdrawable surplus of NIS 77 million at the project level for Afula Phase A, or NIS 52 million at the company-share level, but it states explicitly that the company's right to draw surplus is subordinate to the bank being paid in full first. That means Afula's future economics may look attractive, but they are still not the same thing as cash that is close at hand. That is why the real Series XI test in Afula is not the surplus estimate. It is the first draw.

Herzog 3: The Permit Solved One Condition, Not the Whole Equation

Herzog 3 in Bat Yam looks simpler at first glance. On February 12, 2026, a full building permit was received, and the company describes a 53-apartment project with expected revenue of about NIS 86 million, expected costs of about NIS 69 million, and expected gross profit of about NIS 17 million. The company also says explicitly that receiving the permit is one of the conditions for releasing part of the Series XI proceeds. So it is easy to read that announcement as: yes, the series opened Herzog 3.

But the short reading is too quick here as well. In the trust deed, signed two days earlier, the company had already said that financing agreements with a project lender had been signed for the entire project. At the same time, it said that as of that date the project still had no building permit and no binding apartment-sale contracts. So here too, Series XI did not invent the first financing layer. It attached itself to a project that was already on a lending track, but had not yet crossed the permit threshold and had not yet started to build sales traction.

That is exactly why the permit matters. Not because it turns the project into a large economic engine on its own, but because it moves the story from pre-release paperwork into now we see whether the money actually moves. Herzog 3 is a relatively small project against the broader Elbit Imaging story, and an expected gross profit of about NIS 17 million does not, by itself, carry the whole financing thesis. Its weight here is therefore mostly qualitative: if, after the permit, money is released, execution begins, and the project advances, the market gets proof that the Series XI mechanism really works. If the permit remains mainly a clean legal milestone without operating movement behind it, it will be hard to argue that the series unlocked something truly meaningful.

Bottom Line

Series XI does do more than mechanically refinance old pressure points. It adds a public-capital layer aimed precisely at the slice that sits between developer equity and bank finance, and it is built around two very specific projects. In that sense, this is not just another debt issue meant to extend duration.

But from there to saying that it has already unlocked Afula and Herzog 3, the distance is still meaningful. The money stays in trust until conditions are met, the bank ranks ahead of the bonds in the surplus waterfall, and in Afula especially there is a hard, explicit checklist before the first draw can happen. So Series XI is not a master key. It is a proof test.

What would confirm the thesis: a first draw in Afula, construction start by May 30, 2026, actual proceeds release around Herzog 3, and both projects moving from permits and agreements into execution.

What would challenge it: delays in Afula presales, slippage in lien perfection and proceeds release, or a situation where Herzog 3's permit is not translated quickly enough into marketing and execution, so that public debt mostly replaces old strain instead of creating fresh operating momentum.

If both projects pass that test over the next few months, it will be reasonable to say in hindsight that Series XI opened a door. If not, the series will be remembered less as an accelerator of activity and more as an orderly way to repackage financing tension that was already there.